Stability of placental RNA using dried maternal blood spots

Reproductive BioMedicine Online

Volumn 17, Issue 5, 2008, Pages 716-721

  Jorgez, Carolina J ^a   Bischoff, Farideh Z ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Biocept Inc   (United States)

Author keywords

Dried maternal blood spots; Glyceraldehyde 3 phosphate dehydrogenase; Placental mRNA; Prenatal diagnosis; SHCG

Indexed keywords

CHORIONIC GONADOTROPIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA;

ARTICLE; BLOOD STORAGE; CONTROLLED STUDY; FEMALE; GENETIC CODE; GENETIC SCREENING; HUMAN; MATERNAL BLOOD; PLACENTAL TRANSFER; POPULATION STRUCTURE; PREGNANT WOMAN; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; RNA STABILITY; RNA TRANSCRIPTION; TEMPERATURE;

EID: 56749130833     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60321-5     Document Type: Article

References (24)

1. Alvarez-Munoz MT, Zaragoza-Rodriguez S, Rojas-Montes O et al. 2005 High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions. Archives of Medical Research 36, 382-386.
2. Cao J, Cousins RJ 2000 Metallothionein mRNA in monocytes and peripheral blood mononuclear cells and in cells from dried blood spots increases after zinc supplementation of men. Journal of Nutrition 130, 2180-2187.
3. Cassol S, Gill MJ, Pilon R et al. 1997 Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper. Journal of Clinical Microbiology 35, 2795-2801.
4. Chinnapapagari SK, Holzgreve W, Lapaire O et al. 2005 Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic acids (DNA and mRNA) in maternal plasma. Clinical Chemistry 51, 652-655.
5. Chung GT, Chiu RW, Chan KC et al. 2005a Detrimental effect of formaldehyde on plasma RNA detection. Clinical Chemistry 51, 1074-1076.
6. Chung GT, Chiu RW, Chan KC et al. 2005b Lack of dramatic enrichment of fetal DNA in maternal plasma by formaldehyde treatment. Clinical Chemistry 51, 655-658.
7. Dhallan R, Guo X, Emche S et al. 2007 A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet 369, 474-481.
8. Dhallan R, Au WC, Mattagajasingh S et al. 2004 Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. Journal of the American Medical Association 291, 1114-1119.
9. Fujito N, Samura O, Miharu N et al. 2006 Increased plasma mRNas of placenta-specific 1 (PLAC1) and glial cells-missing 1 (GCM1) in mothers with pre-eclampsia. Hiroshima Journal of Medical Sciences 55, 9-15.
10. Jorgez CJ, Simpson JL, Bischoff FZ 2006 Recovery and amplification of placental RNA from dried maternal blood spots: utility for non-invasive prenatal diagnosis. Reproductive BioMedicine Online 13, 558-561.
11. Karlsson H, Guthenberg C, von Dobeln, U, Kristenssson K 2003 Extraction of RNA from dried blood on filter papers after long-term storage. Clinical Chemistry 49, 979-981.
12. Kopreski MS, Benko FA, Kwak LW, Gocke CD 1999 Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clinical Cancer Research 5, 1961-1965.
13. Lee DH, Li L, Andrus L, Prince AM 2002 Stabilized viral nucleic acids in plasma as an alternative shipping method for NAT. Transfusion 42, 409-413.
14. Lo KW, Lo YM, Leung SF et al. 1999 Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clinical Chemistry 45, 1292-1294.
15. Matsubara Y, Ikeda H, Endo H, Narisawa K 1992 Dried blood spot on filter paper as a source of mRNA. Nucleic Acids Research 20, 1998.
16. McCabe ER, McCabe LL 1999 State-of-the-art for DNA technology in newborn screening. Acta Paediatrica Supplement 88, 58-60.
17. Ng EK, El Sheikhah A, Chiu RW et al. 2004 Evaluation of human chorionic gonadotropin beta-subunit mRNA concentrations in maternal serum in aneuploid pregnancies: a feasibility study. Clinical Chemistry 50, 1055-1057.
18. Ng EK, Leung TN, Tsui NB et al. 2003a The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clinical Chemistry 49, 727-731.
19. Ng EK, Tsui NB, Lau TK et al. 2003b mRNA of placental origin is readily detectable in maternal plasma. Proceedings of the National Academy of Sciences USA 100, 4748-4753.
20. Poon LL, Leung TN, Lau TK, Lo YM 2000 Presence of fetal RNA in maternal plasma. Clinical Chemistry 46, 1832-1834.
21. Purwosunu Y, Sekizawa A, Koide K et al. 2007 Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia. Clinical Chemistry 53, 399-404.
22. Tsui NB, Ng EK, Lo YM 2002 Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clinical Chemistry 48, 1647-1653.
23. Zhang YH, McCabe ER 1992 RNA analysis from newborn screening dried blood specimens. Human Genetics 89, 311-314.
24. Zhong XY, Holzgreve W, Hoesli I, Hahn S 2005 Circulatory corticotropin-releasing hormone mRNA concentrations are increased in women with preterm delivery but not in those who respond to tocolytic treatment. Clinical Chemistry 51, 635-636.